Amgen Inc
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen WEZLANA / WEZENLA (ustekinumab-auub by Quarter
WEZLANA / WEZENLA (ustekinumab-auub — Stelara Biosimilar) — Rest of World (ROW) product sales ($M) ($M)
Amgen WEZLANA / WEZENLA (ustekinumab-auub: $61M in Q2 2026, up 74.3% from a year earlier. That is the highest of the 9 quarters on record here.
Where the Q2 2026 figure comes from
“|| WEZLANA ® /WEZENLA ™ | — | 61 | 61 | 35 | 74%”
Source: Form 8-K (amgn-20260630earningsrelea.htm, filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Product Sales Detail.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | WEZLANA / WEZENLA (ustekinumab-auub — Stelara Biosimilar) — Rest of World (ROW) product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 61 | +74.3% | Form 8-K (amgn-20260630earningsrelea.htm, filed 2026-08-04) ↗ |
| Q1 2026 | Mar 31, 2026 | 43 | +59.3% | Form 8-K (amgn-20260331earningsrelea.htm, filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | 44 | +109.5% | Form 8-K (amgn-20251231earningsrelea.htm, filed 2026-02-03) ↗ |
| Q3 2025 | Sep 30, 2025 | 44 | +780.0% | Form 8-K (amgn-20250930earningsrelea.htm, filed 2025-11-04) ↗ |
| Q2 2025 | Jun 30, 2025 | 35 | – | Form 8-K (amgn-20250630earningsrelea.htm, filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 27 | +2,600.0% | Form 8-K (amgn-20250331earningsrelea.htm, filed 2025-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 21 | – | Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗ |
| Q3 2024 | Sep 30, 2024 | 5 | – | Form 10-Q (amgn-20250930.htm, filed 2025-11-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 1 | – | Form 10-Q (amgn-20250331.htm, filed 2025-05-02) ↗ |
Cite this data
StockData. (2026). Amgen WEZLANA / WEZENLA (ustekinumab-auub ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod-wezlana-row
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.